MM&M ON TWITTER



The Mobile Guide
Trends, data, insights and expert advice on the challenges and opportunities of using mobile to reach healthcare professionals and consumers

MM&M Service Directory Featured Company


MM&M Agency A-to-Z Survey 2011

Don't miss your chance to be a part our definitive annual directory of healthcare agencies! Deadline is June 8th.  For more information contact Ty Bartholomew at 646-638-6015 or ty.bartholomew@haymarketmedia.com.


Salary Survey



 It's YOUR program, so YOU pick the color. Click here now to vote.

The Agency Gallery


White Papers

SUBSCRIBE TO MM&M


MM&M offers the most relevant news, analysis, opinion, feature stories and special reports to nearly 15,000 marketing executives at pharma companies, agencies and in healthcare media. Click here to subscribe.

The MM&M News Brief provides news and features delivered direct to your inbox. To access the full text, simply click the headline.

Latest News

Former sales rep to argue First Amendment protection in court

A federal appeals court has agreed to hear oral arguments about whether the First Amendment protects a sales rep's ability to share information about off-label uses of a drug.
 

Lovitz, J&J poke fun at psoriasis

J&J's Centocor Ortho Biotech is launching a psoriasis awareness campaign featuring sufferer Jon Lovitz.
 

Novartis axing 1,400 US sales jobs due to product changes

Effective January 1, Novartis will reduce its US field force by 1,400 positions, the firm said, as it braces for patent expiries and shifts resources for product launches.
 

From our Sponsor




Essential in Print. Essential Online.

Physicians call the New England Journal of Medicine one of their most essential journals in print.

They also call NEJM.org their most essential website. Completely redesigned, it brings you new ad sizes and specialty targeting to help you reach your most important prospects.

Find out more at nejmadsales.org

In Brief

Company news: AstraZeneca

AstraZeneca chief David Brennan said the company will see nearly a billion dollars shaved off its profits for 2010 and 2011 combined due to healthcare reform legislation in the US, Reuters reported.
 

LATEST FEATURES

Outlook 2011: Eye of the Storm

With a wave of mega-blockbusters set to expire in 2011 and with managed care increasingly in the driver's seat, pharmas will get another bite at the healthcare reform apple and refocus sales efforts on access, reports Matthew Arnold
 

Outlook 2011: The Uptake Curve

Launching a new pharmaceutical or biologic next year? Expect smaller sales than in years past and a gauntlet of more sophisticated payers, physicians and patients. The volatility around a successful launch is higher than ever, says Mike Luby, who offers a dose of reality based on six years of launch data
 

Pipeline 2011: Launch Prospects

MM&M's Pipeline 2011 offers a short list of the so-called locks and long-shots to reach market over the next months and years. You'll find details on 14 specific late-stage candidates, selected based on their potential for approval or impact, along with nearly 200 other therapeutics
 

Headliner: Boehringer Ingelheim's Wa'el Hashad

In October, Boehringer Ingelheim (BI) won FDA approval for Pradaxa, a blood thinner that reduces stroke risk in patients with non-valvular atrial fibrillation. As the first alternative to warfarin, which launched in the 1950s, it's got blockbuster potential.
 

2010/11 PMD




The 2010/11 PMD is the contact resource of choice. Over 17,000 business connections, 4,000 companies and 5,000 new industry names added since the last edition.
Get connected today and order your personal copy.



Advertise
For details on how to advertise in MM&M News Brief, please email Doreen Gates

Unsubscribe
To unsubscribe from the MM&M News Brief click here.
To manage your entire MM&M profile login to your account.

You are subscribed as: %%EMAIL%%

To contact Haymarket Media for general questions or unsubscribe problems, please reply to this email.

All MM&M newsletters are sent from the domain "email.mmm-online.com". When configuring e-mail or spam
filter rules, please use this domain name.

Medical Marketing & Media Magazine
114 W. 26th Street 4th Floor
New York N.Y. 10001
Phone: (646) 638-6000
Fax: (646) 638-6150
http://www.mmm-online.com/

© 2013 Haymarket Media Inc.